HALEOSLABS NSE filing

Haleos Labs: Special Window for Share Transfer Requests Closes with NIL Activity

The RealCase readLow impact Neutral

Haleos Labs reports NIL activity for its 'Special Window' for re-lodgement of physical share transfer requests, which closed on January 6, 2026. No requests were received, processed, approved, or rejected during the window period.

Why it matters

The announcement pertains to a procedural update with no financial impact or significant corporate development. The lack of any share transfer requests processed during the special window indicates minimal impact on the company's operations or stock.

The market read

The announcement is a routine update regarding the closure of a special window for share transfer requests, with no financial implications or significant corporate actions. The lack of activity results in a neutral sentiment.

Haleos Labs Limited, formerly SMS Lifesciences India Limited, has provided an update regarding the 'Special Window' for the re-lodgement of physical share transfer requests, as per SEBI circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025. The company had previously communicated the opening of this window to shareholders via its website and a newspaper publication on July 23, 2025.

The special window was open from July 7, 2025, until January 6, 2026. Haleos Labs, through its Registrar and Share Transfer Agent (RTA), Aarthi Consultants Private Limited, has reported the status of requests received during the period from December 1, 2025, to January 6, 2026.

During this period, the company received zero requests for the re-lodgement of physical share transfer. Consequently, no requests were processed, approved, or rejected. The average time taken for processing requests was also NIL, as there were no applications to process. This update confirms that there was no activity related to the special window during the specified reporting period.

Filing to action

What to do with a filing like this

HALEOS LABS LIMITED filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by HALEOS LABS LIMITED. Read the original for the full detail.

View original filing